Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two Gynecologic Oncology Group (GOG) trials.
about
Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study.Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group studySurvey of Patients with Cervical Cancer in Hospital UniversitiSains Malaysia: Survival Data Analysis with Time-Dependent Covariate.Major clinical research advances in gynecologic cancer 2009.Long-term survival data of triple modality treatment of stage IIB-III-IVA cervical cancer with the combination of radiotherapy, chemotherapy and hyperthermia - an update.Hypoxia biomarkers in squamous cell carcinoma of the uterine cervix.Treatment results of incomplete chemoradiotherapy in locally advanced cervical cancerFactors Predictive of Protracted Course of Radiation Therapy in Patients Treated with Definitive Chemoradiation for Cervical CancerA phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer.Prognostic significance of metastatic lymph node ratio in squamous cell carcinoma of the cervix.Prognostic factors associated with radiotherapy for cervical cancer with computed tomography-detected para-aortic lymph node metastasis.The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy.Adenocarcinoma of the uterine cervix: why is it different?Challenges to delivery and effectiveness of adjuvant radiation therapy in elderly patients with node-positive vulvar cancer.Precision medicine in cancer: challenges and recommendations from an EU-funded cervical cancer biobanking study.Impact of treatment time-related factors on prognoses and radiation proctitis after definitive chemoradiotherapy for cervical cancer.Long-term results and prognostic factors in patients with stage III-IVA squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy from a single institution study.The prognostic impact of overall treatment time on disease outcome in uterine cervical cancer patients treated primarily with concomitant chemoradiotherapy: a nationwide Taiwanese cohort study.Comparison of FDG PET metabolic tumour volume versus ADC histogram: prognostic value of tumour treatment response and survival in patients with locally advanced uterine cervical cancer.
P2860
Q30434661-F11F2A3A-662F-4CED-BE3C-FF6A1E78B8F6Q30436932-FD958DB2-1C41-445E-B309-20A45FEC3419Q30980467-EE1302E4-CC01-4CF4-AD85-DF2872C1D771Q33560967-C7EAAABB-2455-4AA0-B4EF-95BB3C0CC875Q34334498-CC5A7A86-1F55-4EAE-9AF8-661AA2A68151Q35821578-41F64743-E274-4DEF-8698-7DDCC7227E45Q36753297-833387D0-FE03-4719-8336-F1745B72FAEEQ36874439-B756186F-8DB9-40BA-804F-A7BA11E19DE6Q36959090-1567A148-FA90-4E4F-AC28-7356A186E31FQ37042492-11AF58B1-126C-4B5C-94F8-A72F5DDA9CA6Q37450623-03DB2125-A719-44C7-9AFE-A3E69102F267Q38027098-ABB0671C-A19C-46E3-9575-A65844746C8DQ38261137-5392EA5E-608B-49DC-82C0-9390C76671CCQ38785099-AE349CF8-927C-4DAE-A214-1703F09D67CFQ39163320-B3CFED78-F2FD-4BBC-86EC-FED79871C431Q41368193-47425F5E-0200-43C7-9733-D8CC2EB63774Q44619879-2B23F525-29FC-48AE-AE97-C5DF63128152Q45809509-133274B0-7F39-4805-9932-60371EAE24C3Q52868772-814D7D84-17D7-4E2C-99F2-8DF678DC603E
P2860
Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two Gynecologic Oncology Group (GOG) trials.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Which clinical/pathologic fact ...... c Oncology Group (GOG) trials.
@ast
Which clinical/pathologic fact ...... c Oncology Group (GOG) trials.
@en
type
label
Which clinical/pathologic fact ...... c Oncology Group (GOG) trials.
@ast
Which clinical/pathologic fact ...... c Oncology Group (GOG) trials.
@en
prefLabel
Which clinical/pathologic fact ...... c Oncology Group (GOG) trials.
@ast
Which clinical/pathologic fact ...... c Oncology Group (GOG) trials.
@en
P2093
P2860
P1433
P1476
Which clinical/pathologic fact ...... c Oncology Group (GOG) trials.
@en
P2093
Bradley J Monk
Chunqiao Tian
Peter G Rose
Rachelle Lanciano
P2860
P304
P356
10.1016/J.YGYNO.2006.12.027
P407
P577
2007-02-02T00:00:00Z